Implementing shared decision-making: consider all the consequences by Elwyn, G. et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/172770
 
 
 
Please be advised that this information was generated on 2017-12-05 and may be subject to
change.
DEBATE Open Access
Implementing shared decision-making:
consider all the consequences
Glyn Elwyn1* , Dominick L. Frosch2,3 and Sarah Kobrin4
Abstract
Background: The ethical argument that shared decision-making is “the right” thing to do, however laudable, is unlikely
to change how healthcare is organized, just as evidence alone will be an insufficient factor: practice change is governed
by factors such as cost, profit margin, quality, and efficiency. It is helpful, therefore, when evaluating new approaches such
as shared decision-making to conceptualize potential consequences in a way that is broad, long-term, and as relevant as
possible to multiple stakeholders. Yet, so far, evaluation metrics for shared decision-making have been mostly focused on
short-term outcomes, such as cognitive or affective consequences in patients. The goal of this article is to hypothesize a
wider set of consequences, that apply over an extended time horizon, and include outcomes at interactional, team,
organizational and system levels, and to call for future research to study these possible consequences.
Main argument: To date, many more studies have evaluated patient decision aids rather than other approaches to
shared decision-making, and the outcomes measured have typically been focused on short-term cognitive and affective
outcomes, for example knowledge and decisional conflict. From a clinicians perspective, the shared decision-making
process could be viewed as either intrinsically rewarding and protective, or burdensome and impractical, yet studies
have not focused on the impact on professionals, either positive or negative. At interactional levels, group, team, and
microsystem, the potential long-term consequences could include the development of a culture where deliberation
and collaboration are regarded as guiding principles, where patients are coached to assess the value of interventions,
to trade-off benefits versus harms, and assess their burdens—in short, to new social norms in the clinical workplace.
At organizational levels, consistent shared decision-making might boost patient experience evaluations and lead to
fewer complaints and legal challenges. In the long-term, shared decision-making might lead to changes in resource
utilization, perhaps to reductions in cost, and to modification of workforce composition. Despite the gradual shift to
value-based payment, some organizations, motivated by continued income derived from achieving high volumes of
procedures and contacts, will see this as a negative consequence.
Conclusion: We suggest that a broader conceptualization and measurement of shared decision-making would provide
a more substantive evidence base to guide implementation. We outline a framework which illustrates a hypothesized
set of proximal, distal, and distant consequences that might occur if collaboration and deliberation could be achieved
routinely, proposing that well-informed preference-based patient decisions might lead to safer, more cost-effective
healthcare, which in turn might result in reduced utilization rates and improved health outcomes.
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Background
Shared decision-making is widely considered good in
and of itself [1]: healthcare professionals have a duty to
inform people about the benefits and harms of proposed
interventions. These duties are at the core of good
clinical practice. Shared decision-making is defined by
extending this duty to supporting people to arrive at
informed preferences, eliciting and respecting those
preferences by integrating them as decisions are made
[2]. Shared decision-making is distinguished from vari-
ous models of patient-clinician communication, such as
motivational interviewing, by being focused on choice
rather than change [3]. The process is described in more
detail using the terms collaborative deliberation [4]. We
use the terms shared decision-making and collaborative
deliberation interchangeably in this article. Shared
decision-making does not advocate deliberation in every
interaction or for every decision—that would be imprac-
tical. Rather, a deliberative approach is suggested where
the existence of reasonable alternatives justify the work
of informing patients so that they are able to form and
share preferences about them.
It has been argued that shared decision-making repre-
sents the pinnacle of patient-centered care [5]. Epstein’s
summary of the evidence about the healing effect of
good communication [6] has reinforced the ethical im-
perative that practice should be based on collaboration
and deliberation. Yet, despite these arguments and this
evidence, shared decision-making is not widely adopted
in routine clinical practice [7, 8].
Powerful influences drive the practice of medicine, and
so an ethics-based, deontological view, alone, does not lead
to significant change in how healthcare is organized and
delivered. Researchers respond by generating evidence to
support a consequentialist viewpoint. Studies are typically
designed to investigate how shared decision-making might
improve short-term outcomes that are relevant to both
patients and others. Accepting that neither ethical argu-
ments, nor rational evidence, alone or in combination, are
the only factors that predict change in clinical practice, we
noticed limitations in how researchers have evaluated
shared decision-making in published studies.
Evaluation metrics for shared decision-making have been
focused on short-term outcomes, mostly assessing cognitive
or affective effects on patients, with limited agreement
about how to value, and in some cases even how to meas-
ure the desired outcomes. These short-term outcomes have
consequences in the longer term, of course, leading to calls
for healthcare delivery researchers to consider broader
contexts over time, including interventions that simultan-
eously consider patients, clinical teams, organizations and
systems in which they deliver care. These calls suggest the
need to go beyond the evaluation of dyadic interactions to
“include examination of mechanisms and measure of the
effectiveness of healthcare organizations and health systems
in improving outcomes” [9]. Future evaluations might have
more impact if they were able to measure consequences
that are valued by a wider array of stakeholders: patients,
clinicians, as well as organizational managers and
executives, and policy makers [10].
At a time when the sustainability of healthcare delivery
systems is questioned because of high costs and overzeal-
ous medicalization, it is possible that shared decision
making might be an approach that gains wider acceptance.
But existing efforts to study shared decision-making have
mostly focused on how clinicians interact with patients,
without paying attention to team, organizational, and sys-
tem level factors in which these interactions are embedded.
Existing work therefore has for the most part not provided
evidence of sustained change in practice, nor have the tools
that have been advocated become widely embedded into
delivery systems [10, 11]. Despite the policy interest in
shared decision-making, the majority of organizations and
delivery systems of care delivery cite barriers and remain
indifferent to whether shared decision-making is taking
place, with or without patient decision aids [12].
Reflecting on the existing research on shared decision-
making, we suggest that the work to date has had too
narrow a focus, with insufficient agreement on the
conceptualization of shared decision-making, as well as
a conflation of two topics, a shared decision-making
process and the use of patient decision aids.
Most definitions of shared decision-making call for
high-quality information and the participation of patients
in a process of decision-making. That much is uncontro-
versial. However, debate continues on several key issues
that affect assessment of the quality of a shared decision-
making process and how to value commonly measured
short-term outcomes, e.g., the ideal role of patients in a
decision-making process and decision conflict as an out-
come, and whether current measures accurately capture
the increased ambivalence that arises when options are
recognized. Should the preferred role of a patient always
be followed (rather than compel patients to engage in all
decisions)? Insisting that patients engage in decision-
making is the position described by the term mandatory
autonomy [13]. This approach does not receive wide sup-
port but some ethicists argue for it. Most advocates of
shared decision-making take the view that patients should
be engaged in decisions to the extent that they wish to do
so—a position described by the term optional autonomy
[13], as there is some evidence that doing so is helpful
[14]. Nevertheless, further research in this area is needed
to clarify how patient participation, whether desired or
not, affects health outcomes across settings. In terms of
cognitive-affective outcomes, clarity about the ideal
psychological pathway—from option recognition, to
meaningful comparison, and the resolution of the inherent
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emotional work of choosing among alternatives, has not
yet been fully elucidated. Clarity about expected proximal
measures could help us. Different conceptualizations,
measured differently, produce results that are difficult to
compare [15]. Meaningful debate of these and other
questions requires competing hypotheses to be tested.
A second problem, and one which has been partly re-
sponsible for the narrow focus, is the conflation of a shared
decision-making process and the use of patient decision
aids. For a decade or more, there seemed to be a belief that
tools designed to deliver information to patients could lead
patients and clinicians to engage in a process of collabor-
ation and deliberation. This belief was so prevalent that
only one of the randomized trials of patient decision
support conducted between 1990 and 2006 made an effort
to study the interactional process in clinical encounters
[16]. In other studies of patient decision aids, patients
reported being more involved in decisions but there was no
confirmatory evidence from observational data. This
changed when a research group at the Mayo Clinic began
to use observer-based measures as well as patient-reported
outcomes [17]. It is worth noting that the tools under
investigation in the Mayo trials were specifically designed
to create collaborative conversations [18], so the data are
not strictly comparable to studies of patient decision aids
given to patients before clinical encounters. This conflation
has delayed progress on research into the process of shared
decision-making, viewed as a two-way communication. It
has rather led to an emphasis on patient decision aids, to
their development, evaluation, and to the development of
quality “standards.” Insufficient work has been done testing
the assumption that the use of these tools would lead to
shared decision-making [19]. At the same time, this confla-
tion led to significant policy emphasis and legislative
change. The Affordable Care Act in the USA [20] sup-
ported shared decision-making; however, the wording of
the law implies that it could be achieved by incentivizing
the use of patient decision aids [21], and the development
of a certification process to standardize the quality of these
tools, when in fact, we have no evidence that tools on their
own will achieve this goal.
Nevertheless, the results of over 100 trials of patient
decision aids have been consistent. After exposure to the
tools, patients’ knowledge increases, patients make more
accurate assessments of risk, they report more involve-
ment in decision-making, they do not become more
anxious, and they report being more satisfied and more
confident in their decisions [22]. These, in broad terms,
are the typical outcomes that have been measured—de-
scribed by Shay and Lafata as cognitive-affective out-
comes [23]. These outcomes are typically measured soon
after the relevant clinical interactions, testing the
hypothesis that exposure to patient decision aids leads
to positive effects on knowledge, satisfaction, and
perceived involvement, without increasing regret or
decisional conflict.
We suggest that this conceptualization of shared
decision-making is too narrow; it fails to address the
potential relationship between shared decision-making
and a range of consequences that might occur over a
longer span of time if healthcare professionals embraced
the tasks of collaborating with patients to carefully
consider the harms and benefits of potential alternatives.
We argue that it would be timely to consider a wider
range of outcomes where collaborative deliberation has
been achieved [4]. To do so, we would assume that the
research would be able to study settings where clinicians
were both able and willing to accomplish shared decision-
making or that both patients and clinicians were able to
use patient decision support tools as required, or both.
Such settings are difficult to achieve, given that space,
resources, and context will be effect modifiers. Current
healthcare settings, in the USA and elsewhere, have finan-
cial and other incentives that are not well-aligned to
support collaboration and deliberation with patients about
alternative options, although these are changing with
growing emphasis on value-based payment methods [24].
We recognize of course that achieving ideal conditions for
shared decision-making to have its greatest impact is not
easy, but for the purposes of developing a hypothetical
framework—such an assumption allows us to focus on
consequences rather than worry here about the fidelity to
shared decision-making.
The aim of this article is to analyze the work done in
this area and to propose a conceptual framework that
hypothesizes the impact of collaborative deliberation at
individual, interactional, organization, and system levels.
We describe opportunities to examine these consequences
and the possibility of evaluating causal pathways.
Approach
To achieve our goals, we took the following approaches:
1. We considered published work that has examined
outcomes relating to shared decision-making.
We focused on systematic reviews and other
high-quality narrative reviews.
2. We identified research gaps highlighted by existing
reviews and discussed the preliminary results of our
work at academic meetings and conferences.
3. We developed a multilevel framework to describe
potential consequences over time and propose a
sample of questions to illustrate potential future
research directions.
To do the work, we examined a review of outcomes
considered in existing studies of shared decision-making
[23] and analyzed the contribution of patient decision
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aids [22]. In addition, we reviewed other relevant
systematic reviews, including an assessment of whether
patient decision support had led to cost savings [25], the
effect of shared decision-making on health inequalities
[26], on litigation [27], and on treatment satisfaction and
clinical outcomes [28]. After reading these reviews, we
met, face-to-face and virtually, on multiple occasions.
Between meetings, we used a cloud-based document
editing system to develop a figure, tables, and manu-
script. A draft version of the framework was submitted
to a relevant conference [29], where feedback shaped a
penultimate version. We imagined a range of possible
consequences, considering they might be good for some
but not for others, recognizing that different conse-
quences might not be consistently valued by different
stakeholders. As we developed the framework, we de-
cided to group outcomes into those that were proximal,
distal, and distant to a shared decision-making process.
We categorized outcomes by thinking about the level of
impact. Figure 1 provides an overview of a process where
collaborative deliberation leads to an series of hypothe-
sized effects. Table 1 provides more detail. We did not
wish to impose definitive time limits because we acknow-
ledge that divisions will not be precise, and some conse-
quences might accrue gradually [11]. Parsing potential
outcomes into these time frames enabled us to consider
the consequences of collaborative deliberation that go
beyond those that are obvious or easily measured.
Main argument
Many measurement approaches to shared decision-making
have been developed [22, 30, 31]. Shay and Lafata noted
that “the empirical evidence” about the effectiveness of
shared decision-making has not been “systematically sum-
marized” and set about the task [23]. Shay and Lafata found
three sets of reported measures: (1) cognitive-affective, (2)
behavioral, and (3) health outcomes, reporting that patient
“health outcomes were the least studied.” There were no
efforts made to suggest other types of consequences.
Significant efforts to implement patient decision aids
have taken place, mainly in the USA and in the UK [32].
The hospital system at Dartmouth Hitchcock was the
first center dedicated to delivering patient decision aids
[32], and more than a decade later, it continues to offer
such tools to some categories of patients. More recently,
Group Health in Seattle implemented a number of
patient decision tools alongside a quality improvement
initiative aimed at surgical specialists. Evaluations at
Group Health demonstrated high levels of patient
exposure to the tools, higher than those achieved in
other organizations, and evidence of impact on surgical
rates [33]. Others have reported difficulties in attempting
to introduce these tools into organizations [32, 34].
Reviews of efforts made to implement patient decision
aids indicate how difficult it is to alter routine workflows
[35]. Most of the research however has focused on how
to provide decision aids to specific patient groups before
they attend clinic or on how to motivate clinicians to
provide decision aids to relevant patient groups. Much
less attention has been given to research that would
identify organizational, system, and policy factors that
could influence practice change.
Few of these implementation-type studies have consid-
ered the effects of shared decision-making, beyond the
proximal outcomes of decision support interventions given
to patients. The work at Group Health is a notable
exception [28, 33]; their positive results serve to illustrate
what might be possible. Even so, they did not evaluate a
fuller range of consequences or over a time horizon. It is
not therefore possible to conclude much at all about the
mid or longer-term consequences of a concerted effort to
undertake shared decision-making at a system wide level,
whether defined as decision aid use or as a communicative
process of collaboration and deliberation. A handful studies
have included costs and cost-effectiveness, but these have
all been related to the evaluation of patient decision aids
[25]. The results of a systematic review of studies with
economic assessments revealed the need for more and
higher quality studies before firmer conclusions could be
drawn [25]. A systematic review of shared decision-making
in relation to litigation found five studies, mostly case
reports, and was unable to reach a firm conclusion [27].
Conceptual framework
In this section, we provide a figure which illustrates a
hypothesized set of proximal, distal, and distant
Fig. 1 The potential consequences of collaborative deliberation
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Table 1 The potential multilevel consequences of collaborative deliberation
Accomplishing collaborative
deliberation
Proximal effects Distal effects Distant effects
Informed preference; cognitive
and affective effects
Cautious decisions; modified relationships;
enduring trends
Modified utilization and resource use;
modified help seeking behavior
Individual levels Preferences for outcomes and treatments based
on comprehension of high-quality evidence.
Collaborative deliberation generates different
clinician-patient and patient-care team
relationships—with positive and negative potential.
Increased use of interventions that lower risk of harms,
raise likelihood of benefits.
Lower utilization of high-risk, marginal-benefit interventions.Potential conflict where informed patient
preference is not supported by clinician or
organizational policies.
Improved adherence to selected options and less
regret about choices made, improved resilience
and self-efficacy.
Greater engagement in assessing the long-term value of
interventions, leading to lower service utilization
and improved self-management by patients.Realistic expectations with possible changes
in confidence and satisfaction levels. Clinicians experience the synergy of working
to aligned organizational-based incentives. Potential for reduced risk of professional burnout.
Reduced intention to choose intensive treatment
in some settings.
Clinicians experience intrinsic reward for work
done well.
Clinicians experience the cognitive and emotional
work of supporting patients making decisions.
Interactional and group levels Enhanced relationships with clinicians and with
clinical teams
Development of team culture that
generates realistic expectations and
judicious use of resources
Norms established: collaboration and deliberation
become expected behaviors
Dissatisfaction due to decisional burden,
decisional conflict, uncertainty, and concern
about honoring patient preferences.
Patients prompted to ask questions,
assess the value of interventions
Enhanced relationships reduce complaints
and legal challenges.
Exhibiting respect for individuals’ informed
preferences leads to increased satisfaction
with care, at dyadic and group levels.
Organizational levels Many clinicians in an organization become
willing to share information, with patients,
about alternative options.
Higher aggregate patient experience scores,
e.g., satisfaction with care
Change in resource utilization requires workforce changes.
Different utilization patterns lead to changes in
delivery infrastructure and capacity.Higher scores on organizational measures
of patient-centered care.Organizational commitment to resource,
promote, and sustain collaborative deliberation.
Fewer legal challenges.
Improved staff morale, lower incidence of
professional burnout, and less absenteeism.
Redesign of workflow, space, and information
systems will short term require investment.
Healthcare system level Collaborative deliberation viewed as normative,
therefore embedded in policies, systems,
and rewards.
Greater skepticism and scrutiny of new drugs,
interventions, and services.
Lower resource utilization, with trends to more
cost-effective care, that leads to changes in
strategic investment decisions.
Improved cost-effectiveness. System level interest population health, and
its determinants.
Recruits learn and follow different policies.
Reduction in malpractice costs.
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consequences of collaboration and deliberation under-
taken routinely (see Fig. 1), proposing that well-informed
preference-based patient decisions may lead to safer, cost-
effective healthcare, which in turn reduce utilization rates
and improve health outcomes.
To illustrate the potential positive, negative, and po-
tentially peverse consequences, we provide more detail
(see Table 1), where we describe a range of potential
consequences, with commentary below.
Individual consequences—patient and clinician level
As Shay et al. noted, outcomes at the individual level
have been those most commonly considered, where the
majority of interventions have been decision aids given
to patients before clinical encounters and the effects
evaluated soon afterwards [23]. It is reassuring to see
that such tools show that patients develop preferences
based on their comprehension of accessible information,
have more realistic expectations, less “decisional con-
flict” as currently measured, and greater satisfaction.
Emerging evidence also suggests that shared decision-
making can improve adherence and increase trust [8, 36,
37]. It is also reassuring that these tools do not cause
significant anxiety or other problems for patients.
That these tools often reduce the intention to choose
intensive treatments has led to most speculation about
the prospect of modified resource use and possible cost
reduction at distal and distant time points. Nevertheless,
this outcome is understudied [25]. Because of the need
for long-term follow-up, studies that use modeling
methods and sensitivity analyses might be helpful. We
know of no qualitative studies that investigated the
reasons for the lowered interest in some treatments.
Individual level effects on clinicians should also be
considered; the experience of supporting patients in
arriving at informed decisions may be intrinsically
rewarding. Clinicians may also find the effort involved
emotionally and cognitively taxing, adding to their work-
load burden. These consequences for clinicians should
be evaluated and understood as they should be expected
to influence the uptake of shared decision-making.
Interactional and group level consequences
Few studies have examined the impact of shared
decision-making as a communicative process beyond the
effect on patients. Experts in organizational psychology
consider five types of potential outcomes: (1) tangible
outcomes products of teaming, e.g., costs or rates; (2)
attitudes or emergent states, e.g., trust, psychological
safety; (3) cognitive states, e.g., shared mental models;
(4) team behaviors, e.g., turnover or absenteeism; and (5)
norms, e.g., expected behaviors [38]. As the table
proposes, effective shared decision-making may lead to
positive effects at interactional levels, by which we mean,
to enhanced relationships between patients and
clinicians, and to positive communication and processes
in clinical teams and clinical microsystems [39, 40].
Demonstrations that professionals are willing to inform
and then respect patient preferences might lead to
significant positive changes in patient experience, includ-
ing satisfaction metrics, although there remains the risk
that some patients will react negatively to being asked to
participate in decisions and become more aware of un-
certainty about treatment effects. Clinical encounters
that become more difficult to conduct because patients
might not want to take responsibility for participating in
decisions could lead to clinicians who avoid this
approach—such a consequence would need to be
monitored. Longer term interactional consequences of
adopting shared decision-making might be the develop-
ment of a culture where careful deliberation and caution
are regarded as guiding principles, where patients are
coached to assess the long-term value of interventions,
to question the benefits and assess their burdens [4].
Given the evidence that teamwork failures correlate
strongly with technical clinical errors [41], sustained
collaborative deliberation with patients across teams
might lead to social norms that become self-sustaining,
which could be measured. Resource utilization and other
performance scores may improve at group levels [42].
Organizational level consequences
We view a healthcare organization as one composed of
multiple delivery teams or microsystems and of a size
that needs management by higher order functions such
as finance, human resources, and so on, led by an execu-
tive group. For an organization to accomplish shared
decision-making consistently, many clinicians will need
to be willing to share information with patients about
alternative options with patients to support the compari-
sons and consider patient preferences. These tasks will
need knowledge, skills, and, perhaps most importantly, a
widespread shift in attitudes. As we have already noted,
patient decision tools help these processes, especially if in-
tegrated into workflows and electronic record systems.
However, negative consequences will also surface: organi-
zations might resist the investment required and decline
to redesign workflow to facilitate the use of patient know-
ledge tools or refuse to redistribute or substitute work
roles. The professional shifts needed to adopt the attitudes
and skills required might be too risky for organizations
and could lead to workforce problems, given that the work
required to confirm that shared decision-making was
being provided would modify existing work patterns.
Again, achieving high-quality shared decision-making
would likely lead to different scores on measures of
patient experience of care which are of increasing
importance as organizational benchmarks. This is especially
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true if the next generation of patient experience measures
focus on care that has been tailored to individual
preferences. Arguably, such a process could lead to positive
consequences, such as fewer complaints and fewer legal
challenges. Anecdotally, many organizations have invested
in patient information provision, including patient decision
aids, because they are convinced that well-informed
patients are less likely to conduct lawsuits (personal
communication, Emmi Solutions). Expecting and support-
ing clinicians to achieve shared decision-making could also
have a positive effect on organizational morale and could
over time improve lower the incidence of professional
burnout by better aligning clinician’s values with the work
they do [43]. In the long term, if shared decision-making
does lead to substantial changes in resource utilization—-
perhaps reductions in use and cost—clinical workforce
composition will have to be modified. Despite the gradual
shift toward value-based payment for services, some organi-
zations, motivated by continued income derived from
achieving high volumes of procedures and contacts, will see
this consequence as negative. The need to consider the
wider consequences of shared decision-making is rein-
forced by increasing acknowledgement that achieving sus-
tainable change in healthcare delivery systems will require
attention to “organizational fields” [44] and interventions
that address multiple levels of delivery systems [44, 45].
Healthcare system level consequences
By system, we refer to the policies and incentives that
guide the work of organizations. Predicted effects at the
system level are related to the power of norms and routi-
nes—in other words, “how things are normally done,”
especially if these are visible, monitored, and rewarded.
The proximal effect of embedding collaborative deliber-
ation in a normative set of operational delivery processes
is the influence it might have on setting the expectations
for new recruits, having to learn shared decision-making,
and how to use patient decision aids. Setting such norms
reinforces the predicted distal and distant effects, where
greater caution and skepticism may become the expected
organizational cultures in healthcare settings. This new
norm would contrast with settings where the early
adoption of innovative treatment is routinely viewed as
positive, as a way to be at the leading edge, with little
consideration of a benefit-cost consideration. Greater
emphasis on supporting patients to self-manage long
long-term conditions, and have realistic expectations, may
improve cost-effectiveness. Systems that build, sustain,
and maintain such norms are likely to have significantly
lower resource utilization and reductions in malpractice
costs than those that resist collaboration with patients and
continue frequent contacts to generate income.
This section describes many possible consequences
about which little research evidence is available. To
illustrate some potential ways forward, we have outlined
a selection of possible research questions; see Table 2.
Synthesis
By proposing a table that considers three points across
time and four levels of analysis, and some potential
interventions, we are able to highlight a range of poten-
tial consequences, positive and negative, that require
more investigation; some are hypothesized consequences
that have not been explicitly articulated previously.
At the individual level, we propose that the accumu-
lated effects of repeated exposure to collaboration and
deliberation would modify relationships with healthcare
professionals and institutions. Patients, their relatives,
and health professionals would be more likely to
embrace caution, more adherent to options that were
deliberately chosen, and, in due course, those changes
could lead to different decisions about how to access
and use healthcare interventions and resources.
At interactional levels, we postulate that collaborative
deliberation would lead to changes at both dyadic and
team levels, where peer pressure and new social norms
might reinforce the establishment of deliberative decision
Table 2 Examples of emerging research questions
Proximal consequences
• Does the preferred patient role in decision-making lead
to different outcomes?
• What characteristics of patients, process, clinicians,
settings and decisions moderate this relationship?
• Is there sufficient clarity about proximal outcomes and
how they are measured?
• Do we have robust concepts as the basis for measuring decision
process, decision outcomes (confidence, conflict, regret etc.),
and to what degree are these mediators for distal outcomes
such as treatment choice, adherence to chosen treatment,
and other patient determined and patient-reported outcomes.
• Models could be proposed and evaluated in an effort to
elucidate the mediation path from a shared decision
making process to a selected set of consequences.
Distal topics
• Do people who participate in shared decision making prior to
an invasive procedure experience less distress in response to
treatment side effects or adverse events than those who did
not participate in shared decision making?
• Is the distress mediated by more realistic expectations
resulting from the shared decision making?
Distant topics
• How would resource use be affected by the implementation
of shared decision making in different types of healthcare
delivery settings?
• How would implementation of shared decision making prior
to specific procedures affect rates of malpractice investigations
concerning such procedures?
• How might these effects vary by type of healthcare
delivery setting?
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making. At organizational levels, if incentives were aligned
to support collaborative deliberation, the accumulated
effects of this approach might lead to differences in
utilization patterns and quality measures. Measures of
patient-centered care, satisfaction, and care quality might
show improvements and the burden of complaints and
litigation could be reduced. If scaled across multiple
organizations to healthcare system level, positive strategic
and long-term dividends might result.
We based our analysis on existing reviews, attempting
to stimulate thinking about more durable consequences of
shared decision-making. Many have reported challenges
with implementing shared decision-making and patient
decision support tools, which suggests that those who
manage and provide leadership for delivery systems are
not yet convinced that benefits outweigh the investments
required. We intentionally approached the framework
from more than one perspective, consistent with recent
efforts to introduce a multilevel analysis to healthcare
delivery problems [30], and make it more explicit that
shared decision-making might have a broader and deeper
impact than has been articulated to date. We developed a
generic framework so that it can be applied to healthcare
delivery systems irrespective of how they might be funded,
although as we note some of the consequences might be
considered negative for a business model based on contact
frequency or high volume procedures.
This work is provisional, being based on a number of
hypotheses. Our intention is to stimulate debate as well
as to generate new research questions, some of which
we have outlined, in the hope that others will develop
methods to study the relationships. We assume that
these consequences might occur when shared decision
making is consistently accomplished, avoiding known
implementation challenges. We recognize that achieving
such a consistent process will be difficult.
We focus on the research implications, which might
provide additional information to guide healthcare
delivery system investments in practice improvement. We
acknowledge that existing systems do not currently
accomplish shared decision-making so this assumption is
not a valid starting position for researchers; research is
further hampered by the need to find consensus on defini-
tions and measures before findings can be aggregated
effectively and create an evidence base considering the full
range of consequences of shared decision-making.
Research ideas
To address these issues, we propose a range of research
ideas:
 Recruit and study health systems that are willing to
invest in shared decision-making, at clinician, clin-
ical team, managerial, and system levels. Ensure
fidelity by measuring interactional processes at team
levels. Baseline measures of team functioning, staff
turnover, intervention rates, and other quality met-
rics would be available for comparison using time
series analyses. Although some of the postulated
longer term consequences might take a number of
years, distal consequences might be evident sooner,
such as patient-centered metrics, complaint levels,
staff turnover, and team performance levels.
 Address questions at the level of teams in
organizations, recognizing that high functioning
teams might achieve fidelity in accomplishing new
processes rapidly, and therefore exhibit the proposed
consequences in less time. A range of experimental or
observational designs could be used, comparing teams
at different levels of motivation and performance.
 As noted, selecting healthcare systems already
committed to higher quality at lower cost will be
critical. Fortunately, multiple examples of such
organizations are emerging as healthcare systems
strive to become more cost-effective. In the USA,
health reform efforts have introduced the concept of
Accountable Care Organizations that are not based
on fee-for-service payment models. These systems
would be good settings for future evaluations. Health-
care providers in single-payer systems are also well-
placed to test the effect of consistently accomplished
shared decision making, provided they address the
profit-driven influences of payer and provider separ-
ation. The implementation challenge is to ensure that
the organizational governance and reward system is
aligned with delivering consistent levels of collabora-
tive deliberation at the front line rather than by the
volume of work achieved. Research that monitors the
alignment or otherwise of incentives, from the board
room, to clinical management, that directly or indir-
ectly influence front line clinicians would help illu-
minate the reported tensions felt by the clinical
workforce. Research to compare different incentive
frameworks, intrinsic and extrinsic, would be helpful.
Real-world evaluations will be expensive. Another
approach would be to build models that could forecast lon-
ger term consequences, using existing evidence where avail-
able. For example, it is entirely possible that small changes in
the use of diagnostic and screening tests would reduce the
escalator effect of finding hitherto quiescent abnormalities
that lead to further investigation and cascading intervention.
Modeling the degree to which collaborative deliberation
might act as a brake on overdiagnosis, overtreatment, and
iatrogenic harm could help understand which changes in
practice might deliver the most benefit. Further, modeling al-
lows the comparison of competing hypotheses, and assess-
ment of long-term relationships, without the collection of
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new data. Existing data from other domains, such as patient-
reported outcomes from early breast cancer treatment deci-
sions, could be used to create models and from which sensi-
tivity analyses can guide future data collection.
Conclusions
Shared decision-making has been welcomed by policy
makers world wide—it resonates and supports the ethical
imperative of respect for patient autonomy and engagement
[46]. Yet, as we hope this article shows, the potential endur-
ing benefits and unintended consequences of consistently
accomplished collaboration and deliberation have not been
sufficiently laid out and, therefore, not investigated.
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